Aspire Bariatrics Company Update

Aspire Bariatrics, Inc. regrets to inform you that we are winding down all operations at the Company. As a result, we are withdrawing the AspireAssist from the market, effective April 8, 2022. Due to the financial impact of the COVID-19 pandemic, we can no longer afford to continue operations at the Company.

Please note that our withdrawal of the AspireAssist from the market is entirely the result of economic factors, not the result of safety or effectiveness issues associated with or reported with the product. The safety and effectiveness profile of the AspireAssist, as has been found subsequent to when the product received FDA approval (known as a “PMA”) , is consistent with the safety and effectiveness profile of the product when it received FDA approval in June 2016.

Please see our full Letter to Patients here for more information: